Not checkedNot checked for notices yet.

Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer´s disease.

Jonathan Mauricio Muñoz-Cabrera, Adrián Gabriel Sandoval-Hernández, Andrea Niño and 5 more

PLoS ONE · 2019

doi:10.1371/journal.pone.0223578 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

References62

14.
Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits · 2012
24.
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research · 2010

38 more references, whose wording the paper’s licence keeps private.

All 62 references

Cited by papers we hold1

APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease · 2020

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.